Topics

Noven Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

07:14 EDT 16 Aug 2019 | BioPortfolio Reports

Noven Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Noven Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Noven Pharmaceuticals, Inc. Noven or 'the company' develops and sells prescription pharmaceutical products which are marketed under Minivelle, Combipatch and Daytrana brands. These products treat deficit hyperactivity disorder ADHD, womens diseases and central nervous systems disorders. Noven maintains stateofthe art, FDAapproved transdermal manufacturing facilities in Miami which are also approved by the U.S. DEA Drug Enforcement Agency for the production of controlled substances. The company is headquartered in Miami, Florida, the US.


Scope


Detailed information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Noven Pharmaceuticals, Inc. in the form of a SWOT analysis

An indepth view of the business model of Noven Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Noven Pharmaceuticals, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Noven Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Noven Pharmaceuticals, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Noven Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Noven Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Original Article: Noven Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Noven Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Attention deficit hyperactivity disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD) is a group of behavioural symptoms that include inattentiveness, hyperactivity and impulsiveness. Attention deficit disorder (ADD) is a sub-type of ADHD - symptoms of ADHD include: a short attenti...